Pharmacokinetic aspects of the treatment with long-acting injectable antipsychotics and specific features of the first generation preparations
Dlouhodob psobc injekn antipsychotika pekonvaj nkolik problm spojench s dlouhodobou lbou pacient se schizofreni, zejmna problm ast non-adherence. V lb schizofrenie se pouvaj u tm 60 let. Ve srovnn s p. o. preparty vak maj jin principy farmakokinetiky; jej dynamika je dna zejmna mrou vstebvn z msta vpichu. Pi prostm pepotu ekvivalentn dvky je riziko poklesu plazmatick hladiny se zvenm rizikem relapsu; eenm je p. o. suplementace nebo schmata tzv. rychl titrace. Pi pevodu a titraci dvky je vhodn pout TDM. V esk republice jsou k dispozici 4 zstupci antipsychotik 1. generace ve form LAI. Jednotliv ltky se li svmi farmakokinetickmi parametry i doporuenmi schmaty suplementace nebo rychl titrace.
Authors
- Tomáš Skřont (ORCID: https://orcid.org/0000-0001-8134-5518)
- Martin Hýža (ORCID: https://orcid.org/0000-0002-2451-2997)
Publication Details
- Journal
- Psychiatrie pro praxi
- Published
- 2025-07-04
- DOI
- https://doi.org/10.36290/psy.2025.013
- Citations
- 1
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.47